Oxford BioDynamics Plc (AIM:OBD)
0.4750
0.00 (0.00%)
Mar 28, 2025, 2:57 PM GMT+1
Oxford BioDynamics Revenue
In the fiscal year ending September 30, 2024, Oxford BioDynamics had annual revenue of 636.00K GBP with 24.71% growth. Oxford BioDynamics had revenue of 309.00K in the half year ending September 30, 2024, with 347.83% growth.
Revenue
636.00K
Revenue Growth
+24.71%
P/S Ratio
1.91
Revenue / Employee
12.00K
Employees
45
Market Cap
8.17M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 636.00K | 126.00K | 24.71% |
Sep 30, 2023 | 510.00K | 356.00K | 231.17% |
Sep 30, 2022 | 154.00K | -187.00K | -54.84% |
Sep 30, 2021 | 341.00K | -115.00K | -25.22% |
Sep 30, 2020 | 456.00K | -451.00K | -49.72% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Oxford BioDynamics News
- 2 months ago - AIM Market Roundup: Marechale, Oxford Biodynamics, SDX Energy - The Armchair Trader
- 3 months ago - Small Cap Stocks: i-nexus Global, Genip, Oxford Biodynamics - The Armchair Trader
- 3 months ago - Three Quick Facts: Oxford Biodynamics, Entain, Computacenter - The Armchair Trader
- 4 months ago - Small Cap Stocks: Brand Architekts, tinybuild, Quadrise - The Armchair Trader
- 4 months ago - Small Cap Stocks: Rockfire Resources, Fusion Antibodies, Oracle Power - The Armchair Trader
- 5 months ago - Small Cap Stocks: Empyrean, Seascape, Mirriad - The Armchair Trader
- 5 months ago - Oxford Biodynamics shares plummet as company faces cliff edge - The Armchair Trader